VGTel, Inc. (OTCID: VGTL), an astronomy-driven technology company advancing next-generation sensing systems, artificial intelligence, aerospace, and UAP (Unidentified Aerial Phenomena) research ...
NEW YORK, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Raphael Pharmaceutical Inc. (“Raphael Pharmaceutical” or the “Company”) (OTCQB: RAPH), a clinical-stage biotechnology company developing an innovative ...
4d
PharmaTher Announces Filing of U.S. Patent Application for its Peptide Microneedle Patch Technology
Patent filing intended to strengthen PharmaTher's peptide formulation capabilities for PharmaPatch™ while complementing PatchPrint™ as part of the Company's broader microneedle patch development and ...
Continued expansion of IP portfolio related to RNA delivery Treatment of rheumatoid arthritis as one of the key therapeutic indications The provisional patent application describes novel nanoparticle ...
TUCSON, Ariz., March 2, 2026 /PRNewswire/ -- Keys Inc. today announced the filing of U.S. Provisional Patent Application No. 63/939,152 with the United States Patent and Trademark Office (USPTO) ...
LegalZoom’s law firm to provide affordable patent protection through intelligent technology and licensed patent attorneys at a fraction of traditional costs MOUNTAIN VIEW, Calif.--(BUSINESS ...
Continued expansion of IP portfolio related to RNA delivery Treatment of rheumatoid arthritis as one of the key therapeutic indications HAMILTON, BERMUDA / May 1, 2024 / Altamira Therapeutics Ltd.
NEW YORK, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Raphael Pharmaceutical Inc. (RAPH), a clinical-stage biotechnology company developing an innovative research platform based on cannabinoids free of THC and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results